Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04577599 · ClinicalTrials.gov registry record · NA

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

A NA study of Lung Cancer and Lung Neoplasms, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
1,160
Enrollment target
1
Study location

NCT04577599 is a NA study of Lung Cancer and Lung Neoplasms that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 1,160 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04577599, a NA study of Lung Cancer and Lung Neoplasms, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
1,160 participants
Enrollment target
1
Study location

Study Summary

Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.

Interventions

  • OTHER Mobile Low-dose Computed Tomography (LDCT) Screening

Study Locations (1)

North Carolina

  • Levine Cancer Institute - Charlotte

Trial Details

FieldValue
Enrollment Target 1,160 participants
Start Date 2021-01-07
Est. Completion 2028-10
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04577599

The ClinicalTrials.gov registry entry for NCT04577599 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (24% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Mobile Low-dose Computed Tomography (LDCT) Screening is the first listed.

NCT04577599 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04577599 about?

NCT04577599 is a clinical study titled "Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54". Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have th...

What is the current status of trial NCT04577599?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,160 participants. The study started on 2021-01-07. Estimated completion is 2028-10.

What conditions does trial NCT04577599 study?

This clinical trial studies the following conditions: Lung Cancer, Lung Neoplasms.

What interventions are being tested in trial NCT04577599?

The interventions under investigation include: Mobile Low-dose Computed Tomography (LDCT) Screening (OTHER).

Who is sponsoring clinical trial NCT04577599?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04577599 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.